Align Technology Inkomsten in het verleden
Verleden criteriumcontroles 4/6
De winst van Align Technology is gedaald met een gemiddeld jaarlijks percentage van -26.3%, terwijl de winst van de Medical Equipment -industrie jaarlijks groeide met 12%. De inkomsten zijn groeide met een gemiddeld percentage van 11.5% per jaar. Het rendement op het eigen vermogen Align Technology bedraagt 11.2% en de nettomarge bedraagt 11.1%.
Belangrijke informatie
-26.3%
Groei van de winst
-25.6%
Groei van de winst per aandeel
Medical Equipment Groei van de industrie | 8.9% |
Inkomstengroei | 11.5% |
Rendement op eigen vermogen | 11.2% |
Nettomarge | 11.1% |
Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Align Technology: A Change In Plans After Mixed Q3 Earnings
Oct 27Is Now The Time To Look At Buying Align Technology, Inc. (NASDAQ:ALGN)?
Oct 22Align Technology, Inc. (NASDAQ:ALGN) Shares Could Be 31% Below Their Intrinsic Value Estimate
Oct 07Align Technology (NASDAQ:ALGN) Is Reinvesting At Lower Rates Of Return
Sep 22Shareholders Should Be Pleased With Align Technology, Inc.'s (NASDAQ:ALGN) Price
Jul 15Align Technology: The Short-Sellers Are Wrong
Jul 14Is There An Opportunity With Align Technology, Inc.'s (NASDAQ:ALGN) 26% Undervaluation?
Jun 30Is There Now An Opportunity In Align Technology, Inc. (NASDAQ:ALGN)?
Jun 11Align Technology (NASDAQ:ALGN) Will Want To Turn Around Its Return Trends
May 27Align Technology: International Strength To Continue Driving Growth Acceleration
May 07Investors Interested In Align Technology, Inc.'s (NASDAQ:ALGN) Earnings
Apr 01Align Technology: Prospects Are Still Murky, Although There Are Signs Of Hope
Mar 01What Does Align Technology, Inc.'s (NASDAQ:ALGN) Share Price Indicate?
Feb 25Another Look At Align Technology
Feb 23Align Technology's (NASDAQ:ALGN) Strong Earnings Are Of Good Quality
Feb 07Capital Allocation Trends At Align Technology (NASDAQ:ALGN) Aren't Ideal
Jan 03Why We're Not Concerned About Align Technology, Inc.'s (NASDAQ:ALGN) Share Price
Dec 18Estimating The Intrinsic Value Of Align Technology, Inc. (NASDAQ:ALGN)
Nov 18Is It Too Late To Consider Buying Align Technology, Inc. (NASDAQ:ALGN)?
Oct 26The Returns On Capital At Align Technology (NASDAQ:ALGN) Don't Inspire Confidence
Sep 26Align Technology, Inc. (NASDAQ:ALGN) Shares Could Be 33% Above Their Intrinsic Value Estimate
Aug 11What Is Align Technology, Inc.'s (NASDAQ:ALGN) Share Price Doing?
Jul 02Be Wary Of Align Technology (NASDAQ:ALGN) And Its Returns On Capital
Jun 16Does This Valuation Of Align Technology, Inc. (NASDAQ:ALGN) Imply Investors Are Overpaying?
May 02Is There Now An Opportunity In Align Technology, Inc. (NASDAQ:ALGN)?
Mar 27Returns On Capital Signal Tricky Times Ahead For Align Technology (NASDAQ:ALGN)
Mar 09What Is Align Technology, Inc.'s (NASDAQ:ALGN) Share Price Doing?
Dec 23Investors Could Be Concerned With Align Technology's (NASDAQ:ALGN) Returns On Capital
Dec 08Opbrengsten en kosten
Hoe Align Technology geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 24 | 3,961 | 442 | 1,741 | 351 |
30 Jun 24 | 3,943 | 447 | 1,715 | 355 |
31 Mar 24 | 3,917 | 462 | 1,716 | 351 |
31 Dec 23 | 3,862 | 445 | 1,703 | 347 |
30 Sep 23 | 3,807 | 363 | 1,711 | 348 |
30 Jun 23 | 3,737 | 314 | 1,701 | 336 |
31 Mar 23 | 3,705 | 315 | 1,675 | 321 |
31 Dec 22 | 3,735 | 362 | 1,674 | 305 |
30 Sep 22 | 3,864 | 511 | 1,716 | 294 |
30 Jun 22 | 3,990 | 619 | 1,745 | 283 |
31 Mar 22 | 4,031 | 706 | 1,751 | 268 |
31 Dec 21 | 3,953 | 772 | 1,709 | 250 |
30 Sep 21 | 3,756 | 740 | 1,606 | 227 |
30 Jun 21 | 3,474 | 698 | 1,490 | 206 |
31 Mar 21 | 2,816 | 458 | 1,315 | 188 |
31 Dec 20 | 2,472 | 1,776 | 1,201 | 175 |
30 Sep 20 | 2,287 | 1,738 | 1,132 | 168 |
30 Jun 20 | 2,160 | 1,701 | 1,097 | 163 |
31 Mar 20 | 2,409 | 1,889 | 1,108 | 161 |
31 Dec 19 | 2,407 | 443 | 1,072 | 157 |
30 Sep 19 | 2,291 | 419 | 1,019 | 152 |
30 Jun 19 | 2,189 | 417 | 956 | 145 |
31 Mar 19 | 2,079 | 376 | 900 | 137 |
31 Dec 18 | 1,966 | 400 | 852 | 129 |
30 Sep 18 | 1,854 | 313 | 808 | 119 |
30 Jun 18 | 1,734 | 295 | 763 | 111 |
31 Mar 18 | 1,600 | 258 | 714 | 104 |
31 Dec 17 | 1,473 | 231 | 666 | 98 |
30 Sep 17 | 1,345 | 269 | 614 | 93 |
30 Jun 17 | 1,239 | 238 | 571 | 89 |
31 Mar 17 | 1,151 | 219 | 530 | 83 |
31 Dec 16 | 1,080 | 190 | 491 | 76 |
30 Sep 16 | 1,017 | 191 | 460 | 68 |
30 Jun 16 | 946 | 167 | 435 | 65 |
31 Mar 16 | 886 | 148 | 414 | 62 |
31 Dec 15 | 845 | 144 | 390 | 61 |
30 Sep 15 | 814 | 135 | 377 | 61 |
30 Jun 15 | 796 | 145 | 355 | 56 |
31 Mar 15 | 779 | 150 | 338 | 53 |
31 Dec 14 | 762 | 146 | 332 | 53 |
30 Sep 14 | 740 | 149 | 319 | 50 |
30 Jun 14 | 714 | 145 | 311 | 49 |
31 Mar 14 | 684 | 139 | 302 | 46 |
31 Dec 13 | 660 | 64 | 293 | 44 |
Kwaliteitswinsten: ALGN heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (11.1%) ALGN } zijn hoger dan vorig jaar (9.5%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van ALGN is de afgelopen 5 jaar met 26.3% per jaar gedaald.
Versnelling van de groei: De winstgroei van ALGN over het afgelopen jaar ( 21.7% ) overtreft het 5-jarig gemiddelde ( -26.3% per jaar).
Winst versus industrie: De winstgroei ALGN over het afgelopen jaar ( 21.7% ) overtrof de Medical Equipment -sector 10.4%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 11.2% ) van ALGN wordt als laag beschouwd.